Global Dextrose Injection Market Research Report 2023

Publication ID:

PB502234945

Publication Date:

February 7, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Dextrose is also called as glucose as they are chemically identical. It plays a vital role in providing energy to body cells. Dextrose Injection is a non-pyrogenic and sterile solution for caloric supply and fluid replenishment by a single dose. Route of administration of dextrose injection is intravenous i.e. into the vein. Dosage of dextrose injection depends upon weight, age, and clinical condition of the patient. Dextrose 5% in water is injected into the vein to replace lost fluids and also provide carbohydrates to the body. Dextrose 5% in water is also used to treat hypoglycemia (low blood sugar), insulin shock and dehydration (fluid loss). Dextrose is a carbohydrate which is a part of nutrition. Dextrose solution along with amino acids and fats provide nutrition the body. This is called as total parental nutrition. Hyperkalemia is a condition in which potassium levels are high. Dextrose solution (50%) is administered to person suffering from hyperkalemia.
Highlights
The global Dextrose Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Increasing number of launches pertaining to novel dextrose injection products by key players in the market is expected to drive market growth. For instance in 2018, SteriMAx Inc., engaged in production, development, marketing and distribution of essential hospital and retail pharmacy products, launched new drug Bupivacaine Hydrochloride in 8.25% dextrose injection indicated for spinal anesthesia. It is a subarachnoid injection (spinal block).
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dextrose Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dextrose Injection.
The Dextrose Injection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Dextrose Injection market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dextrose Injection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Pfizer
Amphastar
ChanGee
Seqirus
Baxter
Shandong Qidu Pharmaceutical
Sanctus Drugs & Pharmaceuticals
Mountainside Medical
Hospira
B Braun
Segment by Type
5% Dextrose Injection
10% Dextrose Injection
50% Dextrose Injection
70% Dextrose Injection
Segment by Application
First-Aid Treatment
Sports
Trophotherapy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dextrose Injection companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dextrose Injection Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 5% Dextrose Injection
1.2.3 10% Dextrose Injection
1.2.4 50% Dextrose Injection
1.2.5 70% Dextrose Injection
1.3 Market by Application
1.3.1 Global Dextrose Injection Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 First-Aid Treatment
1.3.3 Sports
1.3.4 Trophotherapy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dextrose Injection Market Perspective (2018-2029)
2.2 Dextrose Injection Growth Trends by Region
2.2.1 Global Dextrose Injection Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Dextrose Injection Historic Market Size by Region (2018-2023)
2.2.3 Dextrose Injection Forecasted Market Size by Region (2024-2029)
2.3 Dextrose Injection Market Dynamics
2.3.1 Dextrose Injection Industry Trends
2.3.2 Dextrose Injection Market Drivers
2.3.3 Dextrose Injection Market Challenges
2.3.4 Dextrose Injection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dextrose Injection Players by Revenue
3.1.1 Global Top Dextrose Injection Players by Revenue (2018-2023)
3.1.2 Global Dextrose Injection Revenue Market Share by Players (2018-2023)
3.2 Global Dextrose Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dextrose Injection Revenue
3.4 Global Dextrose Injection Market Concentration Ratio
3.4.1 Global Dextrose Injection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dextrose Injection Revenue in 2022
3.5 Dextrose Injection Key Players Head office and Area Served
3.6 Key Players Dextrose Injection Product Solution and Service
3.7 Date of Enter into Dextrose Injection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dextrose Injection Breakdown Data by Type
4.1 Global Dextrose Injection Historic Market Size by Type (2018-2023)
4.2 Global Dextrose Injection Forecasted Market Size by Type (2024-2029)
5 Dextrose Injection Breakdown Data by Application
5.1 Global Dextrose Injection Historic Market Size by Application (2018-2023)
5.2 Global Dextrose Injection Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Dextrose Injection Market Size (2018-2029)
6.2 North America Dextrose Injection Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Dextrose Injection Market Size by Country (2018-2023)
6.4 North America Dextrose Injection Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dextrose Injection Market Size (2018-2029)
7.2 Europe Dextrose Injection Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Dextrose Injection Market Size by Country (2018-2023)
7.4 Europe Dextrose Injection Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dextrose Injection Market Size (2018-2029)
8.2 Asia-Pacific Dextrose Injection Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Dextrose Injection Market Size by Region (2018-2023)
8.4 Asia-Pacific Dextrose Injection Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dextrose Injection Market Size (2018-2029)
9.2 Latin America Dextrose Injection Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Dextrose Injection Market Size by Country (2018-2023)
9.4 Latin America Dextrose Injection Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dextrose Injection Market Size (2018-2029)
10.2 Middle East & Africa Dextrose Injection Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Dextrose Injection Market Size by Country (2018-2023)
10.4 Middle East & Africa Dextrose Injection Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Dextrose Injection Introduction
11.1.4 Pfizer Revenue in Dextrose Injection Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Amphastar
11.2.1 Amphastar Company Detail
11.2.2 Amphastar Business Overview
11.2.3 Amphastar Dextrose Injection Introduction
11.2.4 Amphastar Revenue in Dextrose Injection Business (2018-2023)
11.2.5 Amphastar Recent Development
11.3 ChanGee
11.3.1 ChanGee Company Detail
11.3.2 ChanGee Business Overview
11.3.3 ChanGee Dextrose Injection Introduction
11.3.4 ChanGee Revenue in Dextrose Injection Business (2018-2023)
11.3.5 ChanGee Recent Development
11.4 Seqirus
11.4.1 Seqirus Company Detail
11.4.2 Seqirus Business Overview
11.4.3 Seqirus Dextrose Injection Introduction
11.4.4 Seqirus Revenue in Dextrose Injection Business (2018-2023)
11.4.5 Seqirus Recent Development
11.5 Baxter
11.5.1 Baxter Company Detail
11.5.2 Baxter Business Overview
11.5.3 Baxter Dextrose Injection Introduction
11.5.4 Baxter Revenue in Dextrose Injection Business (2018-2023)
11.5.5 Baxter Recent Development
11.6 Shandong Qidu Pharmaceutical
11.6.1 Shandong Qidu Pharmaceutical Company Detail
11.6.2 Shandong Qidu Pharmaceutical Business Overview
11.6.3 Shandong Qidu Pharmaceutical Dextrose Injection Introduction
11.6.4 Shandong Qidu Pharmaceutical Revenue in Dextrose Injection Business (2018-2023)
11.6.5 Shandong Qidu Pharmaceutical Recent Development
11.7 Sanctus Drugs & Pharmaceuticals
11.7.1 Sanctus Drugs & Pharmaceuticals Company Detail
11.7.2 Sanctus Drugs & Pharmaceuticals Business Overview
11.7.3 Sanctus Drugs & Pharmaceuticals Dextrose Injection Introduction
11.7.4 Sanctus Drugs & Pharmaceuticals Revenue in Dextrose Injection Business (2018-2023)
11.7.5 Sanctus Drugs & Pharmaceuticals Recent Development
11.8 Mountainside Medical
11.8.1 Mountainside Medical Company Detail
11.8.2 Mountainside Medical Business Overview
11.8.3 Mountainside Medical Dextrose Injection Introduction
11.8.4 Mountainside Medical Revenue in Dextrose Injection Business (2018-2023)
11.8.5 Mountainside Medical Recent Development
11.9 Hospira
11.9.1 Hospira Company Detail
11.9.2 Hospira Business Overview
11.9.3 Hospira Dextrose Injection Introduction
11.9.4 Hospira Revenue in Dextrose Injection Business (2018-2023)
11.9.5 Hospira Recent Development
11.10 B Braun
11.10.1 B Braun Company Detail
11.10.2 B Braun Business Overview
11.10.3 B Braun Dextrose Injection Introduction
11.10.4 B Braun Revenue in Dextrose Injection Business (2018-2023)
11.10.5 B Braun Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Pfizer
Amphastar
ChanGee
Seqirus
Baxter
Shandong Qidu Pharmaceutical
Sanctus Drugs & Pharmaceuticals
Mountainside Medical
Hospira
B Braun

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂